Home - Products - Others - Other Targets - Malvidin-3,5-O-diglucoside chloride

Malvidin-3,5-O-diglucoside chloride

CAS No. 16727-30-3

Malvidin-3,5-O-diglucoside chloride( —— )

Catalog No. M32002 CAS No. 16727-30-3

Malvidin-3,5-O-diglucoside chloride is a natural product.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 468 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Malvidin-3,5-O-diglucoside chloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Malvidin-3,5-O-diglucoside chloride is a natural product.
  • Description
    Malvidin-3,5-O-diglucoside chloride is a natural product.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    16727-30-3
  • Formula Weight
    691
  • Molecular Formula
    C29H35ClO17
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 3,5-Di-O-caffeoylqui...

    3,5-Di-O-caffeoylquinic acid methyl ester exhibits potent inhibitory activities against the formation of advanced glycation end products (AGEs); it exhibits cytotoxicity actions against human cervix carcinoma HeLa cells. 3,5-Di-O-caffeoylquinic acid methyl ester shows high efficiency and low toxicity with antivirus activity against RSV.

  • Trimethylamine hydro...

    Trimethylamine is a product of decomposition of plants and animals. It is the substance mainly responsible for the fishy odor often associated with fouling fish bacterial vagina infections and bad breath. It is also associated with taking large doses of choline.

  • PF-05221304

    PF-05221304 is an orally bioavailable, liver-targeted inhibitor of acetyl-CoA carboxylase (ACC), an enzyme that catalyzes the first committed step in de novo lipogenesis (DNL).